Francesco Franchi
University of Florida College of Medicine Jacksonville · Univesrsity of Florida · University of Florida
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Francesco Franchi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:25 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06691191 · Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 InhibitorsUniversity of Florida · recruiting · Coronary Artery Disease · principal investigator
- Ph4NCT06228456 · Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionUniversity of Florida · recruiting · Coronary Artery Disease · principal investigator
- N/ANCT05332262 · A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial InfarctionUniversity of Florida · recruiting · Coronary Artery Disease · principal investigator
- Ph4NCT04811625 · Pharmacodynamic and Pharmacokinetic Study of PL-ASAPLx Pharma · completed · Healthy Volunteers · principal investigator
- Ph4NCT04668144 · Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCIUniversity of Florida · completed · Coronary Artery Disease, Acute Coronary Syndrome · principal investigator
- Ph4NCT04634162 · PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatmentUniversity of Florida · completed · Coronary Artery Disease · principal investigator
- Ph4NCT03774394 · Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes MellitusUniversity of Florida · completed · Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease (CAD) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:25 UTC. The ranking covers the 200 most relevant of 80 PubMed records, and a shared surname and initials can bring in a namesake. All 80 on PubMed
- 128 citationsRCR 5.6
- Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.J Am Coll Cardiol · 2016110 citationsRCR 3.7
- Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.J Am Coll Cardiol · 2016110 citationsRCR 3.5
- 90 citationsRCR 1.7
- 84 citationsRCR 2.8
- Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients.J Endocrinol Invest · 198082 citationsRCR 3.4
- Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism.J Clin Endocrinol Metab · 200079 citationsRCR 2.6
- 75 citationsRCR 2.8
- Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.JACC Cardiovasc Interv · 201571 citationsRCR 2.3
- Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.J Transl Med · 201856 citationsRCR 2.3